Business Context and Reporting Period
Company: Pacific Biosciences of California, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 1, 2013
Reporting Period: Second Quarter ended June 30, 2013
Context: This filing announces the financial results for the quarter ended June 30, 2013, incorporating a press release (Exhibit 99.1) by reference.
Key Financial Metrics
The provided text serves as a cover document referencing a press release for detailed figures. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this filing text.
- Revenue: Not provided in text.
- Profit/Loss: Not provided in text.
- Cash Flow: Not provided in text.
- Debt and Liquidity: Not provided in text.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that management commentary and outlook are contained within the press release dated August 1, 2013, which is furnished as Exhibit 99.1.
Risks and Contingencies: No specific risks or contingencies are detailed in this 8-K text; the document explicitly states the information is furnished under Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific revenue and net loss figures in the press release (Exhibit 99.1) referenced by this filing.
- Confirm the company's cash position and burn rate as of June 30, 2013, from the full financial statements.
- Review the forward-looking statements and guidance provided in the August 1, 2013 press release.
- Note that this 8-K text itself does not contain the numerical data required for financial modeling.